FTL and cancer: Studies have demonstrated that oxidative stress response proteins, including Nrf2, can activate FTH1 and FTL in cancer cells (Shesh and Connor, 2023), reducing free iron in the labile iron pool (LIP) and inhibiting ferroptosis (Tian et al., 2020; Fang et al., 2021).